Cardioprotective medication use in Black and white breast cancer survivors.

Arnethea L SuttonAshley S FelixDipankar BandyopadhyayReuben RetnamWilliam G HundleyVanessa B Sheppard

Published in: Breast cancer research and treatment (2021)

After adjusting for age and comorbidities, no differences by race in ACEi/BB use were observed. Hypertension was a major contributor of ACEi/BB use in BC survivors.

Keyphrases

growth factor
blood pressure
recombinant human
young adults